Why the study?
VerifyNow PRU values corresponding to platelet hyporesponse or hyper-response to dual antiplatelet therapy associate with thrombotic and hemorrhagic risks, suggesting PRU may offer predictive value.
Does the VerifyNow PRU value predict thrombotic and hemorrhagic events in patients undergoing flow diversion procedures on dual antiplatelet therapy?
Does the VerifyNow PRU value predict thrombotic and hemorrhagic events in patients undergoing flow diversion procedures on dual antiplatelet therapy?
VerifyNow PRU values may offer predictive value for thrombotic and hemorrhagic events during flow diversion procedures.
Answers are grounded in this paper and cite their sources.
May guide PRU-informed DAPT adjustments in flow diversion; extends low-certainty observational data but leaves optimal thresholds open.
VerifyNow PRU values that correspond to platelet hyporesponse or hyper-response to dual antiplatelet therapy are associated with a higher risk of thrombotic and hemorrhagic events, respectively. Thus, the PRU value may offer some predictive value for these events.
No takes yet. Share an insight, caveat, or question.
Ajadi et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: